300869.SHE Contec Medical Systems Co Ltd
- Market cap
- CNY 4.01B
- P/E
- -
- P/B
- 2.33x
- ROE
- -5.9%
- Dividend yield
- 2.80%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 300869.SHE undervalued?
Graham numberThe Graham number of Contec Medical Systems Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Contec Medical Systems Co Ltd fundamental analysis
No fundamental analysis for Contec Medical Systems Co Ltd yet.
Contec Medical Systems Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis, monitoring equipment, and digital healthcare services in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph products, endoscopes, pocket fetal dopplers, feta…
Full company profileContec Medical Systems Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Contec Medical Systems Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 442M | 398M | 363M | 387M | 1.40B | 909M | 712M | 747M | 480M | 468M | 452M |
| Gross Profit | 209M | 193M | 170M | 180M | 810M | 432M | 330M | 387M | 123M | 225M | 219M |
| Operating Income | 96.8M | 84.6M | 69.5M | 81.6M | 715M | 406M | 219M | 187M | -67.6M | -14.0M | -7.09M |
| EBITDA | 135M | 104M | 84.7M | 87.0M | 735M | 429M | 259M | 259M | -11.0M | 38.1M | -62.6M |
| Net Income | 103M | 77.1M | 62.0M | 73.8M | 613M | 352M | 196M | 166M | -77.9M | -24.4M | -98.5M |
| EPS | 0.30 | 0.21 | 0.17 | 0.20 | 1.64 | 0.88 | 0.48 | 0.40 | -0.19 | -0.06 | -0.25 |
| Balance Sheet | |||||||||||
| Total Assets | 495M | 554M | 575M | 679M | 2.10B | 2.79B | 3.73B | 3.21B | 2.73B | 2.77B | 2.64B |
| Total Liabilities | 124M | 108M | 66.1M | 96.0M | 529M | 969M | 1.80B | 1.17B | 868M | 1.04B | 956M |
| Shareholders' Equity | 371M | 447M | 509M | 583M | 1.57B | 1.82B | 1.93B | 2.04B | 1.86B | 1.73B | 1.68B |
| Cash & Short-term Investments | 167M | 226M | 242M | 184M | 814M | 624M | 1.44B | 1.96B | 856M | 983M | 1.06B |
| Total Debt | 845K | 577K | - | 18.9M | 268M | 804M | 1.58B | 1.05B | 785M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 131M | 118M | 29.8M | 50.2M | 598M | 4.65M | 104M | 181M | 62.3M | 22.3M | - |
| Capital Expenditure | 13.7M | 3.06M | 11.9M | 7.43M | 88.7M | 106M | 81.4M | 30.7M | 54.5M | 49.5M | 18.2M |
| Free Cash Flow | 117M | 115M | 17.9M | 42.8M | 509M | -102M | 22.2M | 150M | 7.88M | -27.2M | 48.7M |
| Ratios | |||||||||||
| ROE | 27.9% | 17.3% | 12.2% | 12.7% | 39.1% | 19.4% | 10.2% | 8.1% | -4.2% | -1.4% | -5.9% |
| ROA | 20.9% | 13.9% | 10.8% | 10.9% | 29.2% | 12.6% | 5.3% | 5.2% | -2.9% | -0.9% | -3.7% |
| Net Profit Margin | 23.4% | 19.4% | 17.1% | 19.1% | 43.8% | 38.8% | 27.6% | 22.2% | -16.2% | -5.2% | -21.8% |
| Debt to Equity | 0.00x | 0.00x | - | 0.03x | 0.17x | 0.44x | 0.82x | 0.51x | 0.42x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Contec Medical Systems Co Ltd dividends
- Dividend yield
- 2.80%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 30, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 112M | 0.28 | - |
| 2024 | CNY 128M | 0.31 | - |
| 2023 | CNY 68.7M | 0.17 | 41.4% |
| 2022 | CNY 121M | 0.29 | 61.4% |
| 2021 | CNY 102M | 0.25 | 29.0% |
| 2020 | CNY 1.86M | 0.00 | 0.3% |
| 2019 | CNY 1.86M | 0.01 | 2.5% |
| 2018 | CNY 1.86M | 0.01 | 3.0% |
| 2017 | CNY 1.86M | 0.01 | 2.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Contec Medical Systems Co Ltd
- Insiders 52.44%
- Institutions 1.71%
- Public & others 45.85%
- Shares outstanding 402M
- Free float 189M
Contec Medical Systems Co Ltd company profile
- Company name
- Contec Medical Systems Co Ltd
- Ticker
- 300869.SHE
- ISIN
- CNE1000047F0
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,712
- Fiscal year end
- December
- Address
- No.112 Qinhuang West Street, Qinhuangdao, China, 066004
- Phone
- 86 33 5801 5430
- Website
- contecmed.com
About Contec Medical Systems Co Ltd
Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis, monitoring equipment, and digital healthcare services in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph products, endoscopes, pocket fetal dopplers, fetal monitors, ultrasound diagnostic systems, analyzers, infusion pumps, digital brain electric activity mapping and EMG/EP systems, nebulizers, spirometers, blood glucose meters, uric acid meters, oxygen concentrators, capnographs, and airway pressure devices. It also provides infusion and syringe pumps, massagers, sleep and snoring aids, and thermometers; and telemedicine and veterinary products, dispensing appliances, electronic colposcope, and accessories. In addition, the company engages in the import and export, trade, related consulting, and customer service of medical equipment; marketing activities; technical development, production, and sale of molds; and production and sale of bio-based materials and dental products. It sells its products through distributors. Contec Medical Systems Co.,Ltd was founded in 1996 and is headquartered in Qinhuangdao, China.
Contec Medical Systems Co Ltd management
7- Mr. Yang ZhishanGM & Director · born 1963
- Ms. Min ZhengDeputy GM, Financial Director & Board Secretary · born 1975
- Mr. Guozhi KouDeputy GM & Non-Independent Director · born 1977
- Mr. Chunyuan FuDeputy General Manager · born 1968
- Mr. Zhenhong LiuDeputy General Manager · born 1976
- Mr. Yunlong XuDeputy General Manager · born 1978
- Di WangAccounting Supervisor